Beam Therapeutics (NASDAQ:BEAM) reported its Q3 earnings results on Wednesday, November 8, 2023 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Beam Therapeutics beat estimated earnings by 8.96%, reporting an EPS of $-1.22 versus an estimate of $-1.34.
Revenue was up $1.39 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.34 which was followed by a 0.53% drop in the share price the next day.
Here’s a look at Beam Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.42 | -1.34 | -1.33 | -1.31 |
| EPS Actual | -1.08 | -1.33 | -0.54 | -1.56 |
| Revenue Estimate | 18.05M | 14.08M | 12.53M | 7.94M |
| Revenue Actual | 20.12M | 24.21M | 20.04M | 15.80M |
To track all earnings releases for Beam Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
